Clinical Trial Update: Saroglitazar Magnesium in the Treatment of Non-Alcoholic Steatohepatitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating saroglitazar magnesium for non-alcoholic steatohepatitis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Steatohepatitis

Drugs mentioned

• Saroglitazar Magnesium (saroglitazar magnesium)

Snippet

Sponsor: Zydus Therapeutics Inc. | Conditions: Non Alcoholic Steatohepatitis | Phase 2 | Status: COMPLETED | Results posted: 2024-10-15